Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response

References

• Johnson JA, Cavallari LH. Pharmacogenetics and cardiovascular disease–implications for personalized medicine. Pharmacol Rev. 2013 Jul;65(3):987–1009.
   Google Scholar
• Luizon MR, Pereira DA, Tanus-Santos JE. Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions. Pharmacogenomics. 2018 12;19(18):1423–1435.
   Google Scholar
• Oliveira-Paula GH, Pereira SC, Tanus-Santos JE, et al. Pharmacogenomics and hypertension: current insights. Pharmgenomics Pers Med. 2019;12:341–359.
   Google Scholar
• Gurwitz D, McLeod HL. Genome-wide association studies: powerful tools for improving drug safety and efficacy. Pharmacogenomics. 2009 Feb;10(2):157–159.
   Google Scholar
• Haga SB, LaPointe NM. The potential impact of pharmacogenetic testing on medication adherence. Pharmacogenomics J. 2013 Dec;13(6):481–483.
   Google Scholar
• Lacchini R, Silva PS, Tanus-Santos JE. A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins. Basic Clin Pharmacol Toxicol. 2010 May;106(5):357–361.
   Google Scholar
• Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases. Nitric Oxide. 2017 Feb;63:39–51.
   Google Scholar
• Pereira NL, Rihal CS, So DYF, et al. Clopidogrel Pharmacogenetics. Circ Cardiovasc Interv. 2019 4;12(4):e007811.
   Google Scholar
• Johnson JA, Caudle KE, Gong L, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics-guided Warfarin dosing: 2017 update. Clin Pharmacol Ther. 2017 Sep;102(3):397–404.
   Google Scholar
• Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Endothelial nitric oxide synthase: from biochemistry and gene structure to clinical implications of NOS3 polymorphisms. Gene. 2016 Jan;575(2 Pt 3):584–599.
   Google Scholar
• Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec;329(27):2002–2012.
   Google Scholar
• Walford G, Loscalzo J. Nitric oxide in vascular biology. J Thromb Haemost. 2003 Oct;1(10):2112–2118.
   Google Scholar
• Picón-Pagès P, Garcia-Buendia J, Muñoz FJ. Functions and dysfunctions of nitric oxide in brain. Biochim Biophys Acta Mol Basis Dis. 2019 8;1865(8):1949–1967.
   Google Scholar
• Holotiuk VV, Kryzhanivska AY, Churpiy IK, et al. Role of nitric oxide in pathogenesis of tumor growth and its possible application in cancer treatment. Exp Oncol. 2019 9;41(3):210–215.
   Google Scholar
• Ueki Y, Miyake S, Tominaga Y, et al. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol. 1996 Feb;23(2):230–236.
   Google Scholar
• Gresele P, Momi S, Guglielmini G. Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. Biochem Pharmacol. 2019 8;166:300–312.
   Google Scholar
• Francis SH, Busch JL, Corbin JD, et al. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev. 2010 Sep;62(3):525–563.
   Google Scholar
• Dudzinski DM, Igarashi J, Greif D, et al. The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol. 2006;46:235–276.
   Google Scholar
• Joshi MS, Mineo C, Shaul PW, et al. Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. Faseb J. 2007 Sep;21(11):2655–2663.
   Google Scholar
• Sase K, Michel T. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci. 1995;57(22):2049–2055.
   Google Scholar
• Balligand JL, Kelly RA, Marsden PA, et al. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A. 1993 Jan;90(1):347–351.
   Google Scholar
• Dinerman JL, Dawson TM, Schell MJ, et al. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc Natl Acad Sci U S A. 1994 May;91(10):4214–4218.
   Google Scholar
• Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995 Sep;377(6546):239–242.
   Google Scholar
• Metzger IF, Souza-Costa DC, Marroni AS, et al. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics. 2005 Aug;15(8):565–570.
   Google Scholar
• Metzger IF, Ishizawa MH, Rios-Santos F, et al. Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects. Pharmacogenomics J. 2011 Dec;11(6):393–399.
   Google Scholar
• Lacchini R, Tanus-Santos JE. Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. Pharmacogenomics. 2014 Aug;15(11):1519–1538.
   Google Scholar
• Yoshimura M, Yasue H, Nakayama M, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998 Jul;103(1):65–69.
   Google Scholar
• Yoshimura T, Yoshimura M, Tabata A, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Investig. 2000 Jul-Aug;7(4):238–241.
   Google Scholar
• Azani A, Hosseinzadeh A, Azadkhah R, et al. Association of endothelial nitric oxide synthase gene variants (−786 T>C, intron 4 b/a VNTR and 894 G>T) with idiopathic recurrent pregnancy loss: a case-control study with haplotype and in silico analysis. Eur J Obstet Gynecol Reprod Biol. 2017 Aug;215:93–100.
   Google Scholar
• Kang MK, Kim OJ, Jeon YJ, et al. Interplay between polymorphisms in the endothelial nitric oxide synthase (eNOS) gene and metabolic syndrome in determining the risk of ischemic stroke in Koreans. J Neurol Sci. 2014 Sep;344(1–2):55–59.
   Google Scholar
• Verim L, Toptas B, Ozkan NE, et al. Possible relation between the NOS3 gene GLU298ASP polymorphism and bladder cancer in Turkey. Asian Pac J Cancer Prev. 2013;14(2):665–668.
   Google Scholar
• Amasyali AS, Kucukgergin C, Erdem S, et al. Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases. J Urol. 2012 Dec;188(6):2398–2403.
   Google Scholar
• Demacq C, Vasconcellos VB, Izidoro-Toledo TC, et al. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL). Clin Chim Acta. 2010 Sep;411(17–18):1335–1340.
   Google Scholar
• Cruz-González I, Corral E, Sánchez-Ledesma M, et al. Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study. BMC Cardiovasc Disord. 2009 Aug;9:35.
   Google Scholar
• Olivi L, Gu YM, Salvi E, et al. The −665 C>T polymorphism in the eNOS gene predicts cardiovascular mortality and morbidity in white Europeans. J Hum Hypertens. 2015 Mar;29(3):167–172.
   Google Scholar
• Hoffmann IS, Tavares-Mordwinkin R, Castejon AM, et al. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens. 2005 Mar;19(3):233–240.
   Google Scholar
• Marsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993 Aug;268(23):17478–17488.
   Google Scholar
• Miyamoto Y, Saito Y, Nakayama M, et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a −786T–>C mutation associated with coronary spastic angina. Hum Mol Genet. 2000 Nov;9(18):2629–2637.
   Google Scholar
• Nagassaki S, Sertório JT, Metzger IF, et al. eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med. 2006 Oct;41(7):1044–1049.
   Google Scholar
• Seckin S, Emrah B, Biyik I, et al. 786T/c endothelial nitric oxide synthase gene polymorphism and coronary collateral circulation. Postepy Hig Med Dosw (Online). 2016 Feb;70:80–85.
   Google Scholar
• Khaki-Khatibi F, Yaghoubi AR, Ghojazadeh M, et al. Association between T-786C polymorphism of endothelial nitric oxide synthase gene and level of the vessel dilation factor in patients with coronary artery disease. Mol Biol Res Commun. 2012;1(1):1–71–7. DOI:10.22099/mbrc.2012.198
   Google Scholar
• Shankarishan P, Borah PK, Ahmed G, et al. Endothelial nitric oxide synthase gene polymorphisms and the risk of hypertension in an Indian population. Biomed Res Int. 2014;2014:793040.
   Google Scholar
• Safarinejad MR, Khoshdel A, Shekarchi B, et al. Association of the T-786C, G894T and 4a/4b polymorphisms of the endothelial nitric oxide synthase gene with vasculogenic erectile dysfunction in Iranian subjects. BJU Int. 2011 Jun;107(12):1994–2001.
   Google Scholar
• Salvi E, Kuznetsova T, Thijs L, et al. Target sequencing, cell experiments, and a population study establish endothelial nitric oxide synthase (eNOS) gene as hypertension susceptibility gene. Hypertension. 2013 Nov;62(5):844–852.
   Google Scholar
• Salvi E, Kutalik Z, Glorioso N, et al. Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension. 2012 Feb;59(2):248–255.
   Google Scholar
• Zhang MX, Ou H, Shen YH, et al. Regulation of endothelial nitric oxide synthase by small RNA. Proc Natl Acad Sci U S A. 2005 Nov;102(47):16967–16972.
   Google Scholar
• Zhang MX, Zhang C, Shen YH, et al. Effect of 27nt small RNA on endothelial nitric-oxide synthase expression. Mol Biol Cell. 2008 Sep;19(9):3997–4005.
   Google Scholar
• Staalsø JM, Edsen T, Kotinis A, et al. Association of the NOS3 intron-4 VNTR polymorphism with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2014 Sep;121(3):587–592.
   Google Scholar
• Şener EF, Emiroğulları Ö, Serhatlıoğlu F, et al. The role of endothelial nitric oxide synthase gene G894T and intron 4 VNTR polymorphisms in hemodialysis patients with vascular access thrombosis. Anadolu Kardiyol Derg. 2014 May;14(3):239–243.
   Google Scholar
• Souza-Costa DC, Belo VA, Silva PS, et al. eNOS haplotype associated with hypertension in obese children and adolescents. Int J Obes (Lond). 2011 Mar;35(3):387–392.
   Google Scholar
• Galanakis E, Kofteridis D, Stratigi K, et al. Intron 4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both type 1 and type 2 diabetes in a genetically homogeneous population. Hum Immunol. 2008 Apr-May;69(4–5):279–283.
   Google Scholar
• Liu J, Wang L, Liu Y, et al. The association between endothelial nitric oxide synthase gene G894T polymorphism and hypertension in Han Chinese: a case-control study and an updated meta-analysis. Ann Hum Biol. 2015 Mar;42(2):184–194.
   Google Scholar
• Serrano NC, Casas JP, Díaz LA, et al. Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study. Hypertension. 2004 Nov;44(5):702–707.
   Google Scholar
• Lee YC, Huang SP, Liu CC, et al. The association of eNOS G894T polymorphism with metabolic syndrome and erectile dysfunction. J Sex Med. 2012 Mar;9(3):837–843.
   Google Scholar
• Monti LD, Barlassina C, Citterio L, et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes. 2003 May;52(5):1270–1275.
   Google Scholar
• Podolsky RH, Barbeau P, Kang HS, et al. Candidate genes and growth curves for adiposity in African- and European-American youth. Int J Obes (Lond). 2007 Oct;31(10):1491–1499.
   Google Scholar
• Zhong Q, Chen X, Zhao Y, et al. Association of polymorphisms in pharmacogenetic candidate genes with Propofol susceptibility. Sci Rep. 2017 6;7(1):3343.
   Google Scholar
• Sandrim VC, Yugar-Toledo JC, Desta Z, et al. Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy. J Hypertens. 2006 Dec;24(12):2393–2397.
   Google Scholar
• Mitchell A, Pace M, Nürnberger J, et al. Insulin-mediated venodilation is impaired in young, healthy carriers of the 825T allele of the G-protein beta3 subunit gene (GNB3). Clin Pharmacol Ther. 2005 Jun;77(6):495–502.
   Google Scholar
• Dell’Omo G, Penno G, Pucci L, et al. Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men. J Hypertens. 2007 Jul;25(7):1389–1395.
   Google Scholar
• Kumar SS, Kumar AS, Padmapriya R, et al. Effect of eNOS polymorphisms on salbutamol evoked endothelium dependent vasodilation in South Indian healthy subjects. Indian J Pharmacol. 2013 Jan-Feb;45(1):9–12.
   Google Scholar
• Pacanowski MA, Zineh I, Cooper-Dehoff RM, et al. Genetic and pharmacogenetic associations between NOS3 polymorphisms, blood pressure, and cardiovascular events in hypertension. Am J Hypertens. 2009 Jul;22(7):748–753.
   Google Scholar
• Nasr HB, Dimassi S, M’hadhbi R, et al. Functional G894T (rs1799983) polymorphism and intron-4 VNTR variant of nitric oxide synthase (NOS3) gene are susceptibility biomarkers of obesity among Tunisians. Obes Res Clin Pract. 2016 Jul-Aug;10(4):465–475.
   Google Scholar
• Sofowora G, Dishy V, Xie HG, et al. In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism. Pharmacogenetics. 2001 Dec;11(9):809–814.
   Google Scholar
• Naber CK, Baumgart D, Heusch G, et al. Role of the eNOS Glu298Asp variant on the GNB3825T allele dependent determination of alpha-adrenergic coronary constriction. Pharmacogenetics. 2003 May;13(5):279–284.
   Google Scholar
• Schneider MP, Erdmann J, Delles C, et al. Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J Hypertens. 2000 Dec;18(12):1767–1773.
   Google Scholar
• Geng R, Chen Z, Zhao X, et al. Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy. PLoS One. 2014;9(12):e116027.
   Google Scholar
• Balat A, Alasehirli B, Oguzkan S, et al. Nitric oxide synthase gene polymorphisms in children with primary nocturnal enuresis: a preliminary study. Ren Fail. 2007;29(1):79–83.
   Google Scholar
• Leeson CP, Hingorani AD, Mullen MJ, et al. Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res. 2002 Jun;90(11):1153–1158.
   Google Scholar
• Landau R, Liu SK, Blouin JL, et al. The effect of maternal and fetal β2-adrenoceptor and nitric oxide synthase genotype on vasopressor requirement and fetal acid-base status during spinal anesthesia for cesarean delivery. Anesth Analg. 2011 Jun;112(6):1432–1437.
   Google Scholar
• Linz W, Wohlfart P, Schölkens BA, et al. Interactions among ACE, kinins and NO. Cardiovasc Res. 1999 Aug;43(3):549–561.
   Google Scholar
• Oliveira-Paula GH, Luizon MR, Lacchini R, et al. Gene-Gene interactions among PRKCA, NOS3 and BDKRB2 polymorphisms affect the antihypertensive effects of Enalapril. Basic Clin Pharmacol Toxicol. 2017 Mar;120(3):284–291.
   Google Scholar
• Silva PS, Fontana V, Luizon MR, et al. eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril. Eur J Clin Pharmacol. 2013 Feb;69(2):167–177.
   Google Scholar
• Oliveira-Paula GH, Lacchini R, Luizon MR, et al. Endothelial nitric oxide synthase tagSNPs influence the effects of enalapril in essential hypertension. Nitric Oxide. 2016 5;55–56:62–69.
   Google Scholar
• Oliveira-Paula GH, Lacchini R, Fontana V, et al. Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril. Eur J Clin Pharmacol. 2015 Aug;71(8):949–957.
   Google Scholar
• Vormfelde SV, Sehrt D, Bolte D, et al. Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers. Eur J Clin Pharmacol. 2006 Mar;62(3):195–201.
   Google Scholar
• Mason RP, Jacob RF, Kubant R, et al. Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants. Br J Clin Pharmacol. 2012 Jul;74(1):141–146.
   Google Scholar
• Shindel AW, Kishore S, Lue TF. Drugs designed to improve endothelial function: effects on erectile dysfunction. Curr Pharm Des. 2008;14(35):3758–3767.
   Google Scholar
• Maitland-van der Zee AH, Turner ST, Schwartz GL, et al. A multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazide. Pharmacogenet Genomics. 2005 May;15(5):287–293.
   Google Scholar
• Lenasi H, Kohlstedt K, Fichtlscherer B, et al. Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495. Cardiovasc Res. 2003 Oct;59(4):844–853.
   Google Scholar
• Zhang X, Lynch AI, Davis BR, et al. Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study. PLoS One. 2012;7(3):e34217.
   Google Scholar
• Trial AOaCftACRGTAaL-LTtPHA. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002 Dec;288(23):2981–2997.
   Google Scholar
• Lynch AI, Eckfeldt JH, Davis BR, et al. Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study. Pharmacogenet Genomics. 2012 May;22(5):355–366.
   Google Scholar
• Jáchymová M, Horký K, Bultas J, et al. Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun. 2001 Jun;284(2):426–430.
   Google Scholar
• Gragasin FS, Davidge ST. The effects of propofol on vascular function in mesenteric arteries of the aging rat. Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H466–74.
   Google Scholar
• Oliveira-Paula GH, Lacchini R, Pinheiro LC, et al. Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol. Nitric Oxide. 2018 5;75:77–84.
   Google Scholar
• Rossi GP, Taddei S, Virdis A, et al. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol. 2003 Mar;41(6):938–945.
   Google Scholar
• Godfrey V, Chan SL, Cassidy A, et al. The functional consequence of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in young healthy volunteers. Cardiovasc Drug Rev. 2007;25(3):280–288.
   Google Scholar
• McNamara DM, Tam SW, Sabolinski ML, et al. Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial. J Card Fail. 2009 Apr;15(3):191–198.
   Google Scholar
• Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008 Apr;51(4):960–969.
   Google Scholar
• Sandrim VC, Palei AC, Luizon MR, et al. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension. Pharmacogenomics J. 2010 Feb;10(1):40–45.
   Google Scholar
• Cashen DE, MacIntyre DE, Martin WJ. Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase. Br J Pharmacol. 2002 Jul;136(5):693–700.
   Google Scholar
• Nangle MR, Cotter MA, Cameron NE. An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS gene-deficient mice. Pflugers Arch. 2004 May;448(2):139–145.
   Google Scholar
• Ohashi Y, Kawashima S, Hirata K, et al. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest. 1998 Dec;102(12):2061–2071.
   Google Scholar
• Eisenhardt A, Sperling H, Hauck E, et al. ACE gene I/D and NOS3 G894T polymorphisms and response to sildenafil in men with erectile dysfunction. Urology. 2003 Jul;62(1):152–157.
   Google Scholar
• Peskircioglu L, Atac FB, Erdem SR, et al. The association between intron 4 VNTR, E298A and IVF 23+10 G/T polymorphisms of ecNOS gene and sildenafil responsiveness in patients with erectile dysfunction. Int J Impot Res. 2007 Mar-Apr;19(2):149–153.
   Google Scholar
• Muniz JJ, Lacchini R, Rinaldi TO, et al. Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction. Pharmacogenomics J. 2013 Apr;13(2):189–196.
   Google Scholar
• Yang B, Liu L, Peng Z, et al. Functional variations in the NOS3 gene are associated with erectile dysfunction susceptibility, age of onset and severity in a Han Chinese population. J Sex Med. 2017 4;14(4):551–557.
   Google Scholar
• Shabataev V, Saadat SH, Elterman DS. Management of erectile dysfunction and LUTS/incontinence: the two most common, long-term side effects of prostate cancer treatment. Can J Urol. 2020 Feb;27(1S1):17–24.
   Google Scholar
• Bhatt SR, Lokhandwala MF, Banday AA. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur J Pharmacol. 2011 Sep;667(1–3):258–264.
   Google Scholar
• Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003 Apr;111(8):1201–1209.
   Google Scholar
• Maron BA, Michel T. Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase. Circ J. 2012;76(11):2497–2512.
   Google Scholar
• Pinheiro LC, Oliveira-Paula GH. Sources and effects of oxidative stress in hypertension. Curr Hypertens Rev. 2019 May. DOI:10.2174/1573402115666190531071924.
   Google Scholar
• Muniz JJ, Lacchini R, Sertório JT, et al. Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction. Naunyn Schmiedebergs Arch Pharmacol. 2013 Sep;386(9):805–811.
   Google Scholar
• Oesterle A, Laufs U, Liao JK. Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res. 2017 Jan;120(1):229–243.
   Google Scholar
• Abe K, Nakayama M, Yoshimura M, et al. Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the −786T>C polymorphism. Pharmacogenet Genomics. 2005 May;15(5):329–336.
   Google Scholar
• Kureishi Y, Luo Z, Shiojima I, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 2000 Sep;6(9):1004–1010.
   Google Scholar
• Feron O, Dessy C, Desager JP, et al. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation. 2001 Jan;103(1):113–118.
   Google Scholar
• Wenzel P, Daiber A, Oelze M, et al. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis. 2008 May;198(1):65–76.
   Google Scholar
• Souza-Costa DC, Sandrim VC, Lopes LF, et al. Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. Atherosclerosis. 2007 Aug;193(2):438–444.
   Google Scholar
• Nagassaki S, Herculano RD, Graeff CF, et al. eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. Eur J Clin Pharmacol. 2009 Apr;65(4):385–392.
   Google Scholar
• Kunnas TA, Lehtimäki T, Laaksonen R, et al. Endothelial nitric oxide synthase genotype modulates the improvement of coronary blood flow by pravastatin: a placebo-controlled PET study. J Mol Med (Berl). 2002 Dec;80(12):802–807.
   Google Scholar
• Gromotowicz-Poplawska A, Kloza M, Aleksiejczuk M, et al. Nitric oxide as a modulator in platelet- and endothelium-dependent antithrombotic effect of eplerenone in diabetic rats. J Physiol Pharmacol. 2019 Apr;70(2). DOI:10.26402/jpp.2019.3.04.
   Google Scholar
• Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5193–5197.
   Google Scholar
• Fatini C, Sticchi E, Bolli P, et al. eNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment. Platelets. 2009 Dec;20(8):548–554.
   Google Scholar
• Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011 Mar;57(11):1314–1322.
   Google Scholar
• Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007 Jan;297(2):159–168.
   Google Scholar
• Zeng WP, Zhang R, Li R, et al. Association of the endothelial nitric oxide synthase gene T786C polymorphism with in-stent restenosis in Chinese Han patients with coronary artery disease treated with drug-eluting stent. PLoS One. 2017;12(1):e0170964.
   Google Scholar
• Fang C, Ren X, Zhou H, et al. Effects of eNOS rs1799983 and ACE rs4646994 polymorphisms on the therapeutic efficacy of salvianolate injection in Chinese patients with coronary heart disease. Clin Exp Pharmacol Physiol. 2014 Aug;41(8):558–564.
   Google Scholar
• Lanas A. Role of nitric oxide in the gastrointestinal tract. Arthritis Res Ther. 2008;10(Suppl 2):S4.
   Google Scholar
• Calatayud S, Sanz MJ, Canet A, et al. Mechanisms of gastroprotection by transdermal nitroglycerin in the rat. Br J Pharmacol. 1999 Jul;127(5):1111–1118.
   Google Scholar
• Mallah N, Zapata-Cachafeiro M, Aguirre C, et al. Polymorphisms involved in platelet activation and inflammatory response on aspirin-related upper gastrointestinal bleeding: a case-control study. Front Pharmacol. 2020;11:860.
   Google Scholar
• Mikkola TS, Gissler M, Merikukka M, et al. Sex differences in age-related cardiovascular mortality. PLoS One. 2013;8(5):e63347.
   Google Scholar
• Hishikawa K, Nakaki T, Marumo T, et al. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 1995 Mar;360(3):291–293.
   Google Scholar
• Holm P, Korsgaard N, Shalmi M, et al. Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits. J Clin Invest. 1997 Aug;100(4):821–828.
   Google Scholar
• Clapauch R, Mourão AF, Mecenas AS, et al. Endothelial function and insulin resistance in early postmenopausal women with cardiovascular risk factors: importance of ESR1 and NOS3 polymorphisms. PLoS One. 2014;9(7):e103444.
   Google Scholar
• Tanus-Santos JE, Desai M, Deak LR, et al. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics. 2002 Jul;12(5):407–413.
   Google Scholar
• Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007 Jan;87(1):315–424.
   Google Scholar
• Jadeski LC, Chakraborty C, Lala PK. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int J Cancer. 2003 Sep;106(4):496–504.
   Google Scholar
• Kamm A, Przychodzen P, Kuban-Jankowska A, et al. Nitric oxide and its derivatives in the cancer battlefield. Nitric Oxide. 2019 12;93:102–114.
   Google Scholar
• Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer. 2006 Jul;6(7):521–534.
   Google Scholar
• Sinha BK. Nitric oxide: friend or foe in cancer chemotherapy and drug resistance: a perspective. J Cancer Sci Ther. 2016;8:244–251.
   Google Scholar
• Glover DA, Byrne J, Mills JL, et al. Impact of CNS treatment on mood in adult survivors of childhood leukemia: a report from the Children’s Cancer Group. J Clin Oncol. 2003 Dec;21(23):4395–4401.
   Google Scholar
• Marcoux S, Robaey P, Gahier A, et al. Role of NOS3 DNA variants in externalizing behavioral problems observed in childhood leukemia survivors. J Pediatr Hematol Oncol. 2013 May;35(4):e157–62.
   Google Scholar
• Demas GE, Kriegsfeld LJ, Blackshaw S, et al. Elimination of aggressive behavior in male mice lacking endothelial nitric oxide synthase. J Neurosci. 1999 Oct;19(19):RC30.
   Google Scholar
• Rujescu D, Giegling I, Mandelli L, et al. NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits. Am J Med Genet B Neuropsychiatr Genet. 2008 Jan;147B(1):42–48.
   Google Scholar
• Bayoumy AB, Simsek M, Seinen ML, et al. The continuous rediscovery and the benefit-risk ratio of thioguanine, a comprehensive review. Expert Opin Drug Metab Toxicol. 2020 Feb:1–13. DOI:10.1080/17425255.2020.1719996.
   Google Scholar
• Yarosh DB, Peña A, Brown DA. DNA repair gene polymorphisms affect cytotoxicity in the National Cancer Institute human tumour cell line screening panel. Biomarkers. 2005 Mar-Jun;10(2–3):188–202.
   Google Scholar
• Ghilardi G, Biondi ML, Cecchini F, et al. Vascular invasion in human breast cancer is correlated to T–>786C polymorphism of NOS3 gene. Nitric Oxide. 2003 9;Sep(2):118–122.
   Google Scholar
• Krajinovic M, Elbared J, Drouin S, et al. Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia. Pharmacogenomics J. 2016 11;16(6):530–535.
   Google Scholar
• Beretta GL, Zunino F. Molecular mechanisms of anthracycline activity. Anthracycline chemistry and biology II. Berlin: Springer; 2007. p. 1–19.
   Google Scholar
• Zhou Q, Ding W, Weng Y, et al. NOS3 895G>T and CBR3 730G>A are associated with recurrence risk in non-muscle-invasive bladder cancer with intravesical instillations of THP. Chemotherapy. 2018;63(4):191–197.
   Google Scholar
• van der Zee R, Murohara T, Luo Z, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation. 1997 Feb;95(4):1030–1037.
   Google Scholar
• Zhang R, Wang L, Zhang L, et al. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ Res. 2003 Feb;92(3):308–313.
   Google Scholar
• Namba T, Koike H, Murakami K, et al. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation. 2003 Nov;108(18):2250–2257.
   Google Scholar
• Di Salvatore M, Lo Giudice L, Rossi E, et al. Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis. Clin Transl Oncol. 2016 Jan;18(1):40–46.
   Google Scholar
• Crucitta S, Restante G, Del Re M, et al. Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy. Cancer Chemother Pharmacol. 2019 Dec;84(6):1219–1227.
   Google Scholar
• Di Salvatore M, Pietrantonio F, Orlandi A, et al. IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients. Oncotarget. 2017 Mar;8(10):16887–16898.
   Google Scholar
• Ulivi P, Scarpi E, Passardi A, et al. eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial. J Transl Med. 2015 Aug;13:258.
   Google Scholar
• Eechoute K, van der Veldt AA, Oosting S, et al. Polymorphisms in endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) predict sunitinib-induced hypertension. Clin Pharmacol Ther. 2012 Oct;92(4):503–510.
   Google Scholar
• George DJ, Martini JF, Staehler M, et al. Phase III trial of adjuvant Sunitinib in patients with high-risk renal cell carcinoma: exploratory pharmacogenomic analysis. Clin Cancer Res. 2019 2;25(4):1165–1173.
   Google Scholar
• Casadei Gardini A, Marisi G, Faloppi L, et al. eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study. Oncotarget. 2016 May;7(19):27988–27999.
   Google Scholar
• Kowalski TW, Fraga LR, Tovo-Rodrigues L, et al. New findings in eNOS gene and Thalidomide Embryopathy suggest pre-transcriptional effect variants as susceptibility factors. Sci Rep. 2016 Mar;6(1):23404.
   Google Scholar
• Krause BJ, Hanson MA, Casanello P. Role of nitric oxide in placental vascular development and function. Placenta. 2011 Nov;32(11):797–805.
   Google Scholar
• Ryk C, Koskela LR, Thiel T, et al. Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes. Redox Biol. 2015 Dec;6:272–277.
   Google Scholar
• Jansson OT, Morcos E, Brundin L, et al. The role of nitric oxide in bacillus Calmette-Guérin mediated anti-tumour effects in human bladder cancer. Br J Cancer. 1998 Sep;78(5):588–592.
   Google Scholar
• Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994 Jan;343(8890):133–135.
   Google Scholar
• Ten Broeke R, De Crom R, Van Haperen R, et al. Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir Res. 2006 Apr;7:58.
   Google Scholar
• Iordanidou M, Paraskakis E, Tavridou A, et al. G894T polymorphism of eNOS gene is a predictor of response to combination of inhaled corticosteroids with long-lasting β2-agonists in asthmatic children. Pharmacogenomics. 2012 Sep;13(12):1363–1372.
   Google Scholar
• Sandoo A, Veldhuijzen van Zanten JJ, Metsios GS, et al. Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford). 2011 Nov;50(11):2125–2139.
   Google Scholar
• Pehlivan S, Aydeniz A, Sever T, et al. The functional variants of endothelial nitric oxide synthase gene associated with rheumatoid arthritis in Turkish adults. Clin Rheumatol. 2017 Mar;36(3):537–540.
   Google Scholar
• Takumida M, Anniko M. Brain-derived neurotrophic factor and nitric oxide synthase inhibitor protect the vestibular organ against gentamicin ototoxicity. Acta Otolaryngol. 2002 Jan;122(1):10–15.
   Google Scholar
• Roth SM, Williams SM, Jiang L, et al. Susceptibility genes for gentamicin-induced vestibular dysfunction. J Vestib Res. 2008;18(1):59–68.
   Google Scholar
• Liou YJ, Lai IC, Lin MW, et al. Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia. Pharmacogenet Genomics. 2006 Mar;16(3):151–157.
   Google Scholar